The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...

A rare cell type in the lungs is essential to survival from the COVID-19 virus, a new study shows.

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Editorial: If the human immunodeficiency virus is less well suppressed thanks to President Trump’s cuts to USAID, it risks ...

Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 ...

Researchers from the School of Pharmacy The University of Nottingham in the UK, together with industrial paints manufacturer ...

Economic pressures from steep new US tariffs will push global public debt above pandemic-era levels to nearly 100% of global GDP by the end of the decade as slower growth and trade strain government ...

Following a fall surge of the COVID variant XEC, which led to flu-like symptoms and "wiping people out," there's a new ...

These U.S. decisions will have global impacts, like populations around the world that rely on U.S. funding for HIV treatment and tuberculosis treatment. There will be a lot of death. Public health is ...

Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps ...

A sharp hike in fees at several Delhi schools has left parents frustrated and under financial stress, with many taking to the ...